This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A Phase III randomised, multicentre, double-blind,...
Clinical trial

A Phase III randomised, multicentre, double-blind, therapeutic equivalence study of biosimilar G-CSF (PLIVA/Mayne filgrastim) versus Neupogen (filgrastim-Amgen) in subjects receiving doxorubicin and docetaxel as a combination chemotherapy for breast cance

Read time: 1 mins
Last updated:15th May 2007
To demonstrate the therapeutic equivalence of PLIVA/Mayne filgrastim to Neupogen.
Category Value
Study start date 2007-05-15

View full details